Cowen analyst, Chris Shibutani, reiterated his Outperform rating on shares of Puma Biotechnology (NASDAQ: PBYI) and increased the price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE